AQP3 and urinary bladder carcinoma: Inhibition of AQP3 in bladder cancer cell lines or knockdown of AQP3 in breast and colon cancer cell lines decreases intracellular platinum concentration and attenuates the pro-apoptotic effects of nucleoside analog (5’ DFUR and gemcitabine) treatment, respectively [65, 66].